Tecnimede Group is composed by pharmaceutical companies of private and 100% Portuguese capital. Started its activity in 1980 and covers the entire life cycle of the medicinal products for human use — development, manufacture, promotion and marketing. Its strategy is based on strong investment in Research, Development, and Production of Medicinal Products.
It is intended that the results obtained allow to consolidate the Group's position in the Portuguese market and to strengthen exports and internationalisation. Atlantic Pharma Brasil and Atlas Pharm (Morocco) are an example of the Group's expansion and development of manufacturing plants. Atlantic Pharma Brasil and Atlas Pharm (Morocco) are an example of the Group's expansion and development of manufacturing plants.
The Tecnimede Group was honoured in the Golden Company category at the 30th edition of the IRG Awards (Investor Relations & Governance Awards), a Deloitte initiative.
The IRG Awards aim to reward outstanding achievements from the previous year in the Portuguese financial and business market.
The Jury presented the Golden Company award this year to the Tecnimede Group based on its assessment that the company excels in the values of management and governance transparency and quality, made patent by the company’s size, performance, international presence and future potential.
Winners were selected by an extensive electoral college comprising representatives from entities operating in the financial and business market, and approved by a panel of judges led by Manuel Alves Monteiro. Other members of jury for this edition included Alberto de Castro, António Gomes Mota, António Saraiva, Esmeralda Dourado, João Duque, Jorge Coelho, Luís Amado, Patrícia Teixeira Lopes and Rui Rio.